CORRECTION: CEO, Brady Grainer, From BioCorRx®Inc. Paves Pathways Towards Possible FDA Approval on “Stock Day” Podcast; Aims to Fight Opioid Crisis

CORRECTION: The text below more accurately reflects the audio interview content released January 22nd 2018 and the Company’s products and

Read more